Preoperative chemotherapy for lung cancer does not increase surgical morbidity

scientific article published in April 2001

Preoperative chemotherapy for lung cancer does not increase surgical morbidity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0003-4975(01)02406-7
P698PubMed publication ID11308144

P50authorStephen SwisherQ89454225
Ara A VaporciyanQ107455112
P2093author name stringSmythe WR
Roth JA
Walsh GL
Pisters KM
Putnam JB Jr
Siegenthaler MP
Merriman KW
P2860cites workRevisions in the International System for Staging Lung CancerQ28241070
Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancerQ33491862
Severity scoring and outcome assessment. Computerized predictive models and scoring systemsQ33708312
Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniquesQ35484311
Survival in early-stage non-small cell lung cancerQ40465859
Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus CommitteeQ40760476
Cancer statistics, 1999.Q40817780
Early risk factors for postinjury multiple organ failureQ41004718
Identifying patients with ARDS: time for a different approachQ41704364
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.Q42283680
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.Q52377234
POSSUM scoring system as an instrument of audit in lung resection surgeryQ58410708
Induction chemotherapy before surgery for early-stage lung cancer: A novel approachQ59566197
Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lungQ67486268
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805Q71961890
Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancerQ72123177
Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery GroupQ72595444
Criteria by which to evaluate risk-adjusted outcomes programs in cardiac surgeryQ72855106
A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lungQ72876237
Postoperative complications after combined neoadjuvant treatment of lung cancerQ72963189
Acute respiratory distress syndromeQ73563322
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerQ77475992
Safe pulmonary resection after chemotherapy and high-dose thoracic radiationQ78213664
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P304page(s)1105-11; discussion 1111-2
P577publication date2001-04-01
P1433published inThe Annals of Thoracic SurgeryQ1939819
P1476titlePreoperative chemotherapy for lung cancer does not increase surgical morbidity
P478volume71